Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Nelarabine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 35,748Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XGen Pharm`s Generics Nelarabine Receives Approval in US
    XGen Pharm`s Generics Nelarabine Receives Approval in US

    05 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216510

    FDA
    05 Sep 2024
    Share Share
    Alembic Nelarabine injection gets FDA final approval
    Alembic Nelarabine injection gets FDA final approval

    05 Aug 2024

    // ECONOMICSTIMES

    https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/alembic-nelarabine-injection-gets-fda-final-approval/112225170?utm_source=category_listing&utm_medium=sectionListing

    ECONOMICSTIMES
    05 Aug 2024
    Share Share
    Alembic Pharmaceutical`s Generics Nelarabine Receives Approval in US
    Alembic Pharmaceutical`s Generics Nelarabine Receives Approval in US

    01 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218554

    FDA
    01 Aug 2024
    Share Share
    Gland Pharma`s Generic Nelarabine Receives Approval in the U.S.
    Gland Pharma`s Generic Nelarabine Receives Approval in the U.S.

    03 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212605

    FDA
    03 Jan 2024
    Share Share
    Nexus's Generic Nelarabine Receives Approval in the U.S.
    Nexus's Generic Nelarabine Receives Approval in the U.S.

    02 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215057

    FDA
    02 Jun 2023
    Share Share
    Amneal's Generic Nelarabine Approval in the U.S.
    Amneal's Generic Nelarabine Approval in the U.S.

    04 Apr 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216346

    FDA
    04 Apr 2023
    Share Share